PROPOSAL 3 — APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE OUR AUTHORIZED CAPITAL STOCK
As of April 21, 2022, our Board of Directors unanimously approved, subject to stockholder approval, an amendment to our certificate of incorporation to increase our authorized shares of capital stock from 100,000,000 to 200,000,000 authorized shares of capital stock, comprised of:
•
140,000,00 shares of Class A common stock;
•
20,000,000 shares of Class B common stock; and
•
40,000,000 shares of preferred stock, of which 10,000,000 shall be designated as Series A 9.75% Cumulative Redeemable Perpetual Preferred Stock (“Series A preferred stock”).
The text of the proposed amendment is set forth on Annex B to this Proxy Statement.
We currently have a total of 100,000,000 shares of capital stock authorized under of certificate of incorporation, consisting of 70,000,000 shares of Class A common stock, 20,000,000 shares of Class B common stock and 10,000,000 shares of preferred stock, of which 4,300,000 shares are currently designated Series A preferred stock. Our Board of Directors is asking our stockholders to approve an amendment to our certificate of incorporation which will increase the number of authorized shares of common stock from 100,000,000 to 200,000,000 shares, and increase the number of authorized shares of Class A common stock from 70,000,000 to 140,000,000 shares, and preferred stock from 10,000,000 to 40,000,000 shares, with an increase in the preferred stock designated as Series A preferred stock from 4,300,000 to 10,000,000 shares. There would be no increase in the Class B common stock authorized.
Our Board of Directors has determined that it would be in our best interests to increase the number of authorized shares of capital stock in order to provide our company with the flexibility to pursue all finance and corporate opportunities involving our common stock and preferred stock, which may include private or public offerings of our equity securities, acquisitions, or to issue stock dividends, without the need to obtain additional stockholder approvals. There are currently no formal proposals or agreements that would require an increase in our authorized shares of capital stock. Each additional authorized share of Class A common stock and Series A preferred stock would have the same rights and privileges as each share of currently authorized Class A common stock and Series A preferred stock.
As of April 30, 2022, we had 7,713,992 shares of Class A common stock outstanding, leaving shares of common stock available for issuance. As of April 30, 2022, we had reserved, pursuant to various equity award plans, 2,500,000 shares of Class A common stock, of which 1,560,382 shares were reserved for options currently outstanding and 326,785 were available for future option grants. We also have outstanding 7,654,506 shares of Class B common stock, which votes with the Class A common stock as a single class. Each shares of Class B common stock is substantively identical to the Class A common stock except that each share of Class B common stock provides the holder thereof with ten votes, and is not publicly traded. Each share of Class B common stock may be converted at any time at the election of the holder thereof into one share of Class A common stock. Additionally, as of April 30, 2022, we had warrants outstanding to purchase an aggregate of 4,649,471 shares of common stock issued in connection with financings and acquisitions. As of April 30, 2022, we had 3,903,737 shares of Series A preferred stock outstanding, all of which were issued in connection with financings and acquisitions. We have no other series of preferred stock outstanding.
At present, our Board of Directors has no immediate plans, arrangements or understandings to issue additional shares of Class A common stock or Series A preferred stock other than under our company’s existing at the market plans, and our employee incentive and stock purchase plans. However, we desire to have the shares available to provide additional flexibility to use our common stock and preferred stock for business and financial purposes in the future, including in connection with strategic partnerships, acquisitions and ventures, as well to have sufficient shares available to provide appropriate equity incentives for our employees. The issuance of additional shares of common stock and preferred stock in the future will have the effect of diluting earnings per share, voting power and common and preferred shareholdings of stockholders. It could also have the effect of making it more difficult for a third party to acquire control of our company. The shares will be available for issuance by our Board of Directors for proper corporate